| Date | Title | Description |
| 06.11.2025 | Spanish HealthTech Qida Secures Record €37 Million for Elder Care Expansion | Qida, a Spanish HealthTech innovator, secured €37 million, marking Spain's largest eldercare investment. This funding, led by Quadrille Capital and impact funds, targets serving 100,000 seniors by 2027. Qida plans nationwide expansion, tech... |
| 04.11.2025 | Qida raises Spain’s biggest eldercare round with €37 million to reach 100k seniors by 2027 | Qida, a HealthTech startup based in Sabadell, has secured €37 million in fresh funding to expand its elderly care services across Spain – marking the largest investment ever in the elder care sector in Spain and is one of the biggest for a ... |
| 18.09.2025 | Capital meets care: 10 venture capital firms transforming healthcare across Europe | Venture capital remains one of the cornerstones of Europe’s innovation landscape, fuelling the growth of startups across every sector. In our last list, we spotlighted 15 VC firms focused on sustainability, underlining how investors are sha... |
| 10.09.2025 | Paris’ SafeHeal raises additional €10 million to transform colorectal surgery for cancer patients | French MedTech startup SafeHeal, a medical device innovator transforming colorectal surgery, today announced a €10 million extension of its oversubscribed €35 million Series C financing round.
The extension is led by Asabys Partners through... |
| 19.06.2025 | SpliceBio: $135 Million Series B Raised For Expanding Pipeline Of Genetic Medicines | SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, announced the closing of a $135 million Series B financing co-led by new investors EQT Life Sciences a... |
| 11.06.2025 | EQT Life Sciences Co-Leads USD 135 Million Series B Financing in SpliceBio | EQT Life Sciences Co-Leads USD 135 Million Series B Financing in SpliceBio
Wed, Jun 11, 2025 09:30 CET Report this content
Financing was co-led by EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as... |
| 03.02.2025 | Quibim: Imaging Biomarker Company Raises $50 Million (Series A) | Quibim, a leading health technology company pioneering imaging biomarkers for precision medicine, announced the closing of its $50 million Series A funding round. And the company has experienced remarkable growth in the number of patients a... |
| 29.01.2025 | Quibim's Leap into the U.S. Market: A $50M Investment in Precision Medicine | In the world of health technology, precision is paramount. Quibim, a Valencia-based healthtech company, has just secured a significant $50 million in Series A financing. This funding is not just a number; it’s a lifeline aimed at transformi... |
| 29.01.2025 | Quibim Secures $50M to Advance AI-Powered Imaging Biomarkers for Precision Medicine | What You Should Know:
– Quibim, a leading healthtech company pioneering the use of imaging biomarkers for precision medicine, announced today the close of its $50 million Series A financing.
– The company has experienced remarkable growth i... |
| 28.01.2025 | Quibim, a startup using AI imaging to aid in disease detection, raises $50M
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provi... | A Spanish artificial intelligence startup called Quibim S.L. said today it has closed on a $50 million early-stage funding round to help accelerate the development of its foundational models for medical imaging.
Today’s Series A round was l... |
| 28.01.2025 | HealthTech Quibim’s vision for human digital twins gets €47.9M boost | Quibim, a Valencia-based HealthTech company innovating the use of imaging biomarkers for precision medicine, announced today the close of its €47.9 million Series A financing in order establish US presence.
The financing was led by Asabys (... |
| 31.10.2024 | INBRAIN Neuroelectronics: Pioneering the Future of Brain-Computer Interfaces | In the world of neuroscience, a quiet revolution is brewing. INBRAIN Neuroelectronics, a Barcelona-based company, is at the forefront of this change. Recently, they secured $50 million in Series B funding, pushing their total capital raised... |
| 30.10.2024 | INBRAIN Neuroelectronics: Brain-Computer Interface Therapeutics Company Secures $50 Million (Series B) | INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, announced the closing of a $50 million Series B funding round. The funding round was led by imec.xpand with ne... |
| 26.09.2024 | Asabys Partners Closes Sabadell Asabys II Fund, at €180M | Asabys Partners, a Barcelona, Spain-based life sciences focused venture capital firm, closed its second fund, Sabadell Asabys Health Innovation Investments II (SAHII II), with total commitments of €180m.
LPs included new US and internationa... |
| 10.07.2024 | Augustine Therapeutics: €17 Million Raised For Developing Neurodegenerative And Cardiometabolic Disease Treatments | Augustine Therapeutics, a pioneering biotech company focused on novel treatments for neurodegenerative and cardiometabolic diseases, announced that it has raised €17 million in the first closing of its Series A round. This funding round was... |
| 12.10.2023 | Sidekick Health, participada por Asabys, compra la alemana aidhere y entra en el mercado de las terapias digitales reguladas | 12/10/2023
Nota de prensa
SIDEKICK HEALTH, PARTICIPADA POR ASABYS, COMPRA LA ALEMANA AIDHERE Y ENTRA EN EL MERCADO DE LAS TERAPIAS DIGITALES REGULADAS
Sidekick Health, participada por Asabys, y una de los líderes mundiales en innovación ... |
| 14.09.2023 | El ICF invierte 10M€ en el fondo centrado en salud Sabadell Asabys II | La firma de capital riesgo especializada en salud Asabys ha comunicado la entrada del Institut Català de Finances (ICF) en su nuevo fondo de capital riesgo, Sabadell Asabys Health Innovation Investments II (Sabadell Asabys II), con una part... |
| 08.09.2023 | France-based Gradient Denervation Technologies bag €14M to develop novel pulmonary hypertension therapy | Read this article in:
France-based medtech startup Gradient Denervation Technologies announced on Thursday that it had raised €14M in a Series A round of funding. Asabys Partners led the financing effort through its newly established fund, ... |
| 07.09.2023 | Gradient Denervation Technologies cierra una serie A de €14m liderada por Sabadell Asabys | 07/09/2023
Nota de prensa
GRADIENT DENERVATION TECHNOLOGIES CIERRA UNA SERIE A DE €14M LIDERADA POR SABADELL ASABYS
Gradient Denervation Technologies (“Gradient”), una empresa de dispositivos médicos que desarrolla una solución innovador... |
| 18.07.2023 | Orikine Bio cierra una ronda Seed de €5,5M con Sabadell Asabys y AdBio | 18/07/2023
Nota de prensa
ORIKINE BIO CIERRA UNA RONDA SEED DE €5,5M CON SABADELL ASABYS Y ADBIO
Orikine Bio, compañía de biotecnología que desarrolla una nueva plataforma propia de terapias basadas en citoquinas para enfermedades autoin... |
| 19.04.2023 | Amelia Virtual Care y XRHealth anuncian su fusión en una operación liderada por Asabys | 19/04/2023
Nota de prensa
AMELIA VIRTUAL CARE Y XRHEALTH ANUNCIAN SU FUSIÓN EN UNA OPERACIÓN LIDERADA POR ASABYS.
Amelia Virtual Care (ex Psious), compañía deep-tech especializada en el sector salud con sede en Barcelona, creadores de un... |
| 01.03.2023 | Sabadell Asabys invierte en la Series B de DeepUll que alcanza €17M | 01/03/2023
Nota de prensa
SABADELL ASABYS INVIERTE EN LA SERIES B DE DEEPULL QUE ALCANZA €17M
Asabys anuncia hoy la primera inversión de su nuevo fondo, SAHII II (Sabadell Asabys Healthcare Innovation Investments II) lanzado con el sopor... |
| 15.02.2023 | Asabys Partners announces €100m first close for health and biotech fund | Barcelona-based health and life science-focused VC Asabys Partners is announcing a €100m first close of its second fund.
It’s targeting a total of €200m — which it hopes to hit later this year — and will look to invest in startups with scie... |
| 16.11.2022 | SpliceBio recibe el premio a la “Serie A del año” en los European Lifestars awards | 16/11/2022
Nota de prensa
SPLICEBIO RECIBE EL PREMIO A LA “SERIE A DEL AÑO” EN LOS EUROPEAN LIFESTARS AWARDS
SpliceBio, compañía biotecnológica de terapia génica con sede en Barcelona basada en tecnología desarrollada en la Universidad d... |
| 15.09.2022 | Asabys lanza Sabadell Asabys Health Innovation Investments II con un tamaño objetivo de €200M | 15/09/2022
Nota de prensa
ASABYS LANZA SABADELL ASABYS HEALTH INNOVATION INVESTMENTS II CON UN TAMAÑO OBJETIVO DE €200 MILLONES.
La gestora de capital riesgo Asabys ha anunciado hoy el lanzamiento de un nuevo fondo, Sabadell Asabys Healt... |
| 28.06.2022 | Amelia Virtual Care cierra una ronda de €7M dando entrada a ENDRA y CDTI. Participan Sabadell Asabys, Caixa CR y CG Ventures | 28/06/2022
Nota de prensa
AMELIA VIRTUAL CARE DA ENTRADA A NUEVOS INVERSORES Y REFUERZA SU EQUIPO DIRECTIVO.
ENDRA y CDTI Innvierte lideran una nueva inversión en la compañía dotándola con un total de €7 millones en el último año, donde t... |
| 10.05.2022 | Nuage Therapeutics, participada por Asabys Partners, incorpora a Judit Anido como Consejera Delegada | 10/05/2022
Nota de prensa
NUAGE THERAPEUTICS INCORPORA A LA EMPRENDEDORA Y EJECUTIVA JUDIT ANIDO COMO CONSEJERA DELEGADA.
• Judit Anido se une a Nuage Therapeutics como co-fundadora y CEO (Chief Executive Officer) y pasa a ser miembro de... |
| 05.05.2022 | Sidekick raises $55M Series B lead by Novator Ventures, and also backed by Asabys and Frumtak Ventures | 05/05/2022
Press release
DIGITAL THERAPEUTICS LEADER SIDEKICK RAISES $55M SERIES B TO DRIVE FURTHER GROWTH.
● The closing of the company’s B Series follows an oversubscribed $20m A round in 2020.
● The funding allows Sidekick to acceler... |
| 05.05.2022 | More than a Sidekick! Iceland’s digital therapeutics player kicks in $55 million to boost chronic disease treatments | The next generation of therapeutics designed to prevent, treat and help people manage a wide range of medical disorders, digital therapeutics is the way forward.
Betting big on the segment, Icelandic digital therapeutics platform Sidekick H... |
| 05.05.2022 | Sidekick cierra una ronda Serie B de $55M liderada por Novator Ventures. Acuden también Asabys, Wellington Partners y Frumtak Ventures | 05/05/2022
Nota de prensa
SIDEKICK, LÍDER EN TERAPIAS DE SALUD DIGITALES PARTICIPADA POR SABADELL ASABYS, CIERRA UNA SERIE B DE $55M PARA IMPULSAR SU CRECIMIENTO.
● La compañía levantó una ronda de financiación Serie A de $20m en 2020 li... |
| 18.02.2022 | Asabys Partners eleva a €117M su primer fondo con la entrada del FEI | 18/02/2022
ASABYS PARTNERS ELEVA A €117 MILLONES SU PRIMER FONDO CON LA ENTRADA DEL FEI.
La gestora de capital riesgo (venture capital) Asabys Partners, especializada en biomedicina, ha elevado el tamaño de su primer fondo hasta los €117 ... |
| 16.02.2022 | SpliceBio raises €50M Series A round co-lead by UCB Ventures and Ysios, and also backed by New Enterprise, Gilde, NovartisVF and Asabys | 16/02/2022
Nota de prensa
SPLICEBIO RAISES €50M IN OVERSUBSCRIBED SERIES A FINANCING TO ADVANCE PROTEIN SPLICING PLATFORM AND EXPAND GENE THERAPY PIPELINE.
• Financing co-led by UCB Ventures and Ysios Capital with participation by New En... |
| 04.10.2021 | Finanțări pentru startup-uri medicale europene prin fonduri de investiții de 1,7 miliarde Euro | Startup-urile și firme mai dezvoltate, care inovează în medicină și alte științe ale vieții, au la dispoziție finanțări totale 1,7 miliarde de euro, prin 8 fonduri de investiții europene, susținute de UE și de mari companii, precum Google.
... |
| 28.09.2021 | Nuage Therapeutics secures a round backed by Asabys Partners | 28/09/2021
Press release
NUAGE THERAPEUTICS, THE SPIN-OFF FROM IRB BARCELONA AND ICREA, IS LAUNCHED WITH THE SUPPORT OF ASABYS.
• Nuage Therapeutics is a spin-off of IRB Barcelona and ICREA and was founded by the researchers Xavier Salva... |
| 28.09.2021 | Nuage Therapeutics cierra una ronda a la que acude Asabys Partners | 28/09/2021
Nota de prensa
LA SPIN-OFF DEL IRB BARCELONA E ICREA, NUAGE THERAPEUTICS, ARRANCA DE LA MANO DE ASABYS.
• Nuage Therapeutics, spin-off del IRB Barcelona e ICREA, ha sido fundada por los investigadores Xavier Salvatella, Mateus... |
| 06.07.2021 | Asabys Partners cierra su primer fondo rozando los €90 millones | 06/07/2021
ASABYS CIERRA SU PRIMER FONDO ROZANDO LOS €90 MILLONES.
La entidad de capital riesgo (venture capital) Asabys cerrará su primer fondo especializado en startups de ciencias de la vida rozando los €90 millones, según informa Plan... |
| 13.05.2021 | Asabys Partners certifica con Bureau Veritas su sistema de gestión de la RSC alineado con los Objetivos de Desarrollo Sostenible (ODS) de la ONU | 13/05/2021
Nota de prensa
ASABYS PARTNERS CERTIFICA CON BUREAU VERITAS SU SISTEMA DE GESTIÓN DE LA RSC ALINEADO CON LOS OBJETIVOS DE DESARROLLO SOSTENIBLE (ODS) DE LA ONU.
Barcelona, a 13 de mayo de 2021: Asabys Partners, gestora de capi... |
| 26.03.2021 | INBRAIN Neuroelectronics raises over €14M Series A led by Asabys Partners, Alta Life Sciences and CDTI to develop intelligent graphene-based neuroelectronic therapies for brain related disorders |
INBRAIN Neuroelectronics is a spin-off company from Graphene Flaship partners’ the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, established in 2019 in the intersection between Medtech, DeepTech and Digital Hea... |
| 26.03.2021 | INBRAIN Neuroelectronics cierra una ronda Series A de más de €14M liderada por Asabys, Alta Life Sciences y CDTI. Participan Vsquared, TruVenturo e ICF | 26/03/2021
Nota de prensa
INBRAIN NEUROELECTRONICS CIERRA UNA RONDA SERIES A DE MÁS DE €14 MILLONES LIDERADA POR ASABYS PARTNERS, ALTA LIFE SCIENCES Y CDTI. PARTICIPAN VSQUARED VENTURES, TRUVENTURO E ICF.
INBRAIN Neuroelectronics es una ... |
| 26.03.2021 | INBRAIN Neuroelectronics raises over €14M Series A led by Alta Life Sciences, Asabys Partners and CDTI to develop intelligent graphene-based neuroelectronic therapies for brain related disorders | Barcelona, March 26th , 2021
INBRAIN Neuroelectronics is a spin-off company from Graphene Flaship partners’ the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, established in 2019 in the intersection between Medtech, ... |
| 08.03.2021 | El Ayuntamiento de Barcelona selecciona a Aldea, 4Founders, Suma Capital, Sabadell Asabys, Invivo y The Extension Fund para canalizar los €10M del Barcelona Acelera | 08/03/2021
EL AYUNTAMIENTO DE BARCELONA SELECCIONA A ALDEA, 4FOUNDERS, SUMA CAPITAL, SABADELL ASABYS, INVIVO Y THE EXTENSON FUND PARA CANALIZAR LOS €10 MILLONES DEL BARCELONA ACELERA.
El Ayuntamiento de Barcelona ya ha seleccionado los fo... |
| 11.02.2021 | MedLumics cierra una ronda de €18M a la que acuden Kurma Partners, VI Partners Swiss, CDTI, Asabys Partners, Andera Partners, Caixa Capital Risc e Innogest | 11/02/2021
Nota de prensa
MEDLUMICS CIERRA UNA RONDA DE €18 MILLONES. PARTICIPAN, ENTRE OTROS, KURMA PARTNERS, CDTI, ASABYS PARTNERS, ANDERA PARTNERS, CAIXA CAPITAL RISC E INNOGEST.
La empresa española de dispositivos médicos MedLumics h... |
| 10.02.2021 | Koa Health cierra la mayor ronda en salud digital en España con €30M, acuden el fondo suizo MTIP, Akilia Partners, Creas Impacto, Sabadell Asabys y Mundi Ventures | 10/02/2021
KOA HEALTH CIERRA LA MAYOR RONDA EN SALUD DIGITAL EN ESPAÑA CON €30 MILLONES, ACUDEN EL FONDO SUIZO MTIP, AKILIA PARTNERS, CREAS IMPACTO, SABADELL ASABYS Y MUNDI VENTURES.
Koa Health ha cerrado la mayor ronda de financiación de... |
| 17.12.2020 | Asabys Partners amplía capital de su primer fondo en ocho millones | 17/12/2020
ASABYS PARTNERS AMPLÍA CAPITAL DE SU PRIMER FONDO EN €8 MILLONES.
La gestora de capital riesgo (venture capital) Asabys Partners ha ampliado capital en €8 millones a través de la sociedad Sabadell Asabys Health Innovation Inves... |
| 28.10.2020 | Sidekick raises $20M in Series A funding round led by Wellington and Asabys | 28/10/2020
Press release
SIDEKICK RAISES $20M IN SERIES A FUNDING ROUND LED BY WELLINGTON AND ASABYS.
Nordic digital therapeutics company Sidekick Health has completed a $20 million oversubscribed Series A financing round led by Wellingt... |
| 28.10.2020 | Digital therapeutics leader Sidekick raises $20M in Series A funding round led by Wellington and Asabys | Nordic digital therapeutics company Sidekick Health has completed a $20 million oversubscribed Series A financing round led by Wellington Partners and Asabys Partners, through its fund SAHII, with participation by existing investors Novator... |
| 28.10.2020 | Digital therapeutics leader Sidekick raises $20M in Series A funding round led by Wellington and Asabys | BARCELONA, Spain, MUNICH, and REYKJAVIK, Iceland, Oct. 28, 2020 /PRNewswire/ -- Nordic digital therapeutics company Sidekick Health has completed a $20 million oversubscribed Series A financing round led by Wellington Partners and Asabys Pa... |
| 28.10.2020 | Asabys Partners y Wellington Partners lideran una ronda de $20M en Sidekick | 28/10/2020
Nota de prensa
ASABYS Y WELLINGTON LIDERAN UNA RONDA DE $20 MILLONES EN SIDEKICK.
• Sidekick opera una plataforma de salud digital que permite desarrollar programas terapéuticos para tratar múltiples patologías
• La compañía ... |
| 09.10.2020 | Medlumics raises €14M in a Series E financing co-led by Asabys Partners, VI Partners and CDTI Innvierte, together with existing investors Andera Partners, Caixa Capital Risc and Innogest | Medlumics, which develops Ablaview®, a unique RF irrigated ablation catheter system that merges photonics and miniaturized optics to guide device placement and directly assess the ablation lesions in real time, announces today the closing o... |
| 08.10.2020 | Medlumics cierra una ronda de €14M co-liderada por Asabys Partners, VI Partners y CDTI Innvierte, junto con los inversores actuales Andera Partners, CaixaCR e Innogest Capital | 08/10/2020
Nota de prensa
MEDLUMICS CIERRA UNA RONDA DE €14M CO-LIDERADA POR ASABYS PARTNERS, VI PARTNERS Y CDTI INNVIERTE, JUNTO CON LOS INVERSORES ACTUALES ANDERA PARTNERS, CAIXACR E INNOGEST CAPITAL.
• Medlumics desarrolla un catéter ... |
| 22.09.2020 | La compañía israelí Medasense cierra una ronda Serie C de $18M a la que acuden Baxter, Asabys Partners, Olive Tree Ventures, LGL Capital, otros fondos y FFOO | 22/09/2020
Nota de prensa
ASABYS INVIERTE EN LA COMPAÑÍA ISRAELÍ MEDASENSE.
• Asabys Partners, desde su vehículo Sabadell Asabys, ha participado en la ronda de financiación Series C de Medasense junto con inversores como Baxter, Olive Tr... |
| 15.09.2020 | ProteoDesign anuncia una nueva ronda de financiación liderada por Ysios Capital. Acuden Asabys Partners y Caixa Capital Risc | 15/09/2020
Nota de prensa
PROTEODESIGN ANUNCIA UNA NUEVA RONDA DE FINANCIACIÓN LIDERADA POR YSIOS CAPITAL Y RENUEVA SU MARCA BAJO EL NOMBRE DE SPLICE BIO.
– Splice Bio, antes ProteoDesign, está especializada en el desarrollo de nuevas te... |
| 01.09.2020 | Asabys Partners anuncia la incorporación de Anna Bellmunt | 01/09/2020
Nota de prensa
ASABYS PARTNERS ANUNCIA LA INCORPORACIÓN DE ANNA BELLMUNT.
La firma de capital riesgo (venture capital) Asabys Partners anunció hoy la incorporación de Anna Bellmunt al equipo de inversiones de la compañía. Anna... |
| 07.07.2020 | Origo Biopharma cierra una ronda semilla de €2,3M liderada por Asabys. Participan XesGalicia y socios promotores | 07/07/2020
Nota de prensa
ORIGO BIOPHARMA CIERRA UNA RONDA SEMILLA DE €2,3M LIDERADA POR ASABYS. PARTICIPAN XESGALICIA Y SOCIOS PROMOTORES.
• Origo Biopharma, fundada en Galicia por GalChimia y Julio Castro (Palobiofarma), y actualmente ... |
| 16.06.2020 | Alta Life Sciences invests in Ona Therapeutic’s €30M Series A | Barcelona, Spain, June 16th 2020: Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announces today the closing of a €30 million Series A financing, with participation f... |
| 11.06.2020 | Inbrain Neuroelectronics cierra una ronda de €1M liderada por Sabadell Asabys y Alta LS | 11/06/2020
INBRAIN NEUROELECTRONICS CIERRA UNA RONDA DE €1 MILLÓN LIDERADA POR SABADELL ASABYS Y ALTA LIFE SCIENCES.
Inbrain Neuroelectronics ha cerrado una ronda de €1 millón liderada por las firmas de capital riesgo (venture capital) Sa... |
| 11.06.2020 | SABADELL ASABYS Y ALTA LIFE SCIENCES APUESTAN POR EL GRAFENO EN EL ÁMBITO DE LAS TERAPIAS ELECTRONICAS NEURONALES Y COLIDERAN LA INVERSIÓN EN INBRAIN NEUROELECTRONICS | Barcelona, 17 de junio de 2020
INBRAIN desarrolla dispositivos de grafeno inteligentes para la modulación electrónica neuronal contra trastornos cerebrales como el Parkinson y la Epilepsia entre otros
INBRAIN, spin-off del Instituto Catal... |
| 02.03.2020 | FOND-ICO Global entra en Sabadell Asabys Health Innovation con €15 millones | 02/03/2020
Nota de prensa
FOND-ICO GLOBAL ENTRA EN SABADELL ASABYS HEALTH INNOVATION CON €15 MILLONES.
La entidad de capital riesgo (venture capital) Asabys Partners ha anunciado el tercer cierre del fondo Sabadell Asabys Health Innovati... |
| 02.09.2019 | Asabys Partners refuerza su primer fondo con una ampliación de capital de €4,84 millones | 02/09/2019
ASABYS PARTNERS REFUERZA SU PRIMER FONDO CON UNA AMPLIACIÓN DE CAPITAL DE €4,84 MILLONES.
La gestora de capital riesgo (venture capital) Asabys Partners, ha reforzado su primer fondo especializado en ciencias de la vida y de la... |
| 18.07.2019 | Alantra desembarca en startups del sector salud con la compra del 35% del fondo Sabadell Asabys Health | 18/07/2019
Nota de prensa
ALANTRA DESEMBARCA EN STARTUPS DEL SECTOR SALUD CON LA COMPRA DEL 35% DEL FONDO SABADELL ASABYS HEALTH INNOVATION INVESTMENTS.
Asabys Partners y Alantra han alcanzado un acuerdo para la entrada de Alantra como s... |
| 19.06.2019 | Asabys Partners lidera junto con Johnson&Johnson una ronda serie A de €6 millones en Cara Care | 19/06/2019
ASABYS PARTNERS LIDERA JUNTO CON JOHNSON&JOHNSON UNA RONDA SERIE A DE €6 MILLONES EN CARA CARE.
La gestora de capital riesgo (venture capital) Asabys Partners, liderada por Josep Lluís Sanfeliu y Clara Campàs, ha liderado j... |
| 18.06.2019 | Cara Care Nabs $7M to Expand Digital Therapuetic App for Digestive Diseases | Berlin, Germany-based digital health company Cara Care, announced today that it has secured $7 million in Series A funding led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Barcelona-based VC firm Asabys Partners with particip... |
| 21.05.2019 | Ona Therapeutics cierra una ronda de €1,5 millones aportados por Asabys Partners | 21/05/2019
Nota de prensa
ONA THERAPEUTICS CIERRA UNA RONDA DE €1,5 MILLONES APORTADOS POR ASABYS PARTNERS.
Ona Therapeutics ha anunciado hoy el cierre de una ronda de financiación semilla de 1,5 millones de euros aportados en su totalid... |
| 10.05.2019 | AXIS resuelve la undécima convocatoria de Fond-ICO Global | 10/05/2019
Nota de prensa
AXIS RESUELVE LA UNDÉCIMA CONVOCATORIA DE FOND-ICO GLOBAL.
• Fond-ICO Global invertirá cerca de 166 millones de euros en los diez fondos seleccionados en esta ronda, y a su vez los fondos elegidos invertirán un ... |
| 03.05.2019 | Psious cierra una ronda de €6M liderada por Asabys Partners, acuden también CaixaCR, SabadellVC y Smartech Capital | 03/05/2019
PSIOUS CIERRA UNA RONDA DE €6 MILLONES LIDERADA POR ASABYS PARTNERS, ACUDEN TAMBIÉN CAIXA CAPITAL RISC, SABADELL VENTURE CAPITAL Y SMARTECH CAPITAL.
Psious ha cerrado una ronda de €6 millones liderada por la entidad de capital ... |
| 08.03.2019 | El fondo Sabadell Asabys Health Innovation Investments arranca de la mano de Asabys Partners con un capital comprometido de €30 millones | 08/03/2018
Nota de prensa
EL FONDO SABADELL ASABYS HEALTH INNOVATION INVESTMENTS ARRANCA DE LA MANO DE ASABYS PARTNERS CON UN CAPITAL COMPROMETIDO DE €30 MILLONES.
Sabadell Asabys Health Innovation Investments ha iniciado su andadura con... |
| 21.12.2018 | Asabys ficha como vocal a Josep Maria Gascón, con el 20-25% de su fondo comprometido | 21/12/2018
ASABYS FICHA COMO VOCAL A JOSEP MARÍA GASCÓN, CON EL 20-25% DE SU FONDO COMPROMETIDO.
Asabys Partners, la gestora de capital riesgo liderada por el ex socio de Ysios Capital, Josep Lluís Santfeliu, ha incorporado a la firma com... |
| 11.05.2018 | Josep Ll. Sanfeliu se desvincula de Ysios Capital y crea Asabys Partners | 11/05/2018
JOSEP LL. SANFELIU SE DESVINCULA DE YSIOS CAPITAL Y CREA ASABYS PARTNERS.
La entidad de capital riesgo (venture capital) Ysios Capital, gestora española líder en inversiones en el sector biotecnológico, ha anunciado hoy la desv... |
| - | More than a Sidekick! Iceland’s digital therapeutics player kicks in $55 million to boost chronic disease treatments | The next generation of therapeutics designed to prevent, treat and help people manage a wide range of medical disorders, digital therapeutics is the way forward.
Betting big on the segment, Icelandic digital therapeutics platform Sidekick H... |
| - | XRHealth Secures $6M to Enhance Immersive VR/AR Experiences | What You Should Know:
– XRHealth, the leading healthcare platform in Spatial Computing, announced today a $6M funding round led by Asabys Partners, with participation from NOVA Prime Fund and XRHealth’s existing investors.
– This milestone ... |
| - | Medlumics raises €14M in a Series E financing co-led by Asabys Partners, VI Partners and CDTI Innvierte, together with existing investors Andera Partners, Caixa Capital Risc and Innogest
| Medlumics develops a unique real-time, photonically guided radiofrequency (RF) irrigated ablation catheter to improve the treatment of Atrial Fibrillation
The proceeds from the Series E financing will be used to complete the preclinical de... |
| - | Cara Care Raises $7M Series A Led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Asabys Partners | Company will use funds to scale its Cara Care digital therapeutic for life-interrupting digestive diseases
Digital health company HiDoc Technologies GmbH, dba Cara Care, today announced that it has raised $7 million in Series A funding. Th... |
